Europe Compounding Pharmacies Market: Size, Insights, Competition, and Forecast (2023-2028)

The Europe Compounding Pharmacies Market has been analysed by Country (United Kingdom, Germany, France, Italy, Spain, Russia, Turkey, Benelux, Nordic, and Rest of Europe).
HOUSTON - Jan. 12, 2023 - PRLog -- The European Compounding Pharmacies Market is projected to display significant growth represented by a CAGR of 8.25% during 2023–2028. The European Compounding Pharmacies Market was valued at USD 3314.80 Million in the year 2021 with Italy holding the largest market share. In terms of segments, the availability of a diverse range of compounded formulas for dermatological purposes will drive segment expansion. Patients who are allergic to commercial pharmaceuticals might benefit from dermatology customised treatments.

Scope of the Report
  • The report presents the analysis of the European Compounding Pharmacies Market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.
  • The report analyses the Europe Compounding Pharmacies Market by Value (USD Million).
  • The report analyses the Europe Compounding Pharmacies by Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, and Other Sources).
  • The report analyses the Europe Compounding Pharmacies Market), by End Users (Adult, Pediatric, Others, Geriatric, Veterinary).
  • The report analyses the Europe Compounding Pharmacies Market by Type (Oral, Topical, Ophthalmic, Injectables, and Others Types).
  • The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by country, by Therapeutic Area, by End Users, by Type.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, and recent developments. The companies analysed in the report include Athenex, Baxter International, Fagron, Grifols, Capsa Healthcare, Nephron Pharmaceuticals, B. Braun, Fresenius, McKesson and Omnicell.

For more Information:

Derrick Samson

(Business Development Manager)

Address:  1321 Upland Dr. PMB 15832

Houston, Texas, 77043,


Mobile: +1 832 495 4885

Mail ID -

Derrick Samson
+1 832 495 4885
Source: » Follow
Email:*** Email Verified
Tags:Europe Compounding Pharmacies
Location:Houston - Texas - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Azoth Analytics News
Most Viewed
Daily News

Like PRLog?
Click to Share